A new role for an old molecule: Serotonin as a mitogen

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 5 16-5, 1997, Pages

  Fanburg, Barry L ^a   Lee, Sheu Ling ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Receptor; Signal transduction; Transporter; Vascular and nonvascular cell growth

Indexed keywords

CELL SURFACE RECEPTOR; CYCLIC NUCLEOTIDE; MITOGENIC AGENT; SEROTONIN; SEROTONIN RECEPTOR;

ACTIVE TRANSPORT; BLOOD VESSEL TONE; CELL GROWTH; CELL PROLIFERATION; GENE CONTROL; GROWTH REGULATION; HYPOXIA; LUNG CIRCULATION; MITOGENESIS; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; REVIEW; SEROTONIN UPTAKE; SIGNAL TRANSDUCTION; SYSTEMIC CIRCULATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0030954150     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.5.l795     Document Type: Review

References (156)

1. Amara, S. G., and M. J. Kuhar. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 16: 73-93, 1993.
2. Araki, S., Y. Kawahara, H. Fuluzaki, and Y. Takai. Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cells. Atherosclerosis 83: 29-34, 1990.
3. 2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth muscle cells. Biochem. J. 288: 527-532, 1992.
4. Atanossoff, P. G., B. N. Weiss, E. R. Schmid, and M. Tornic. Pulmonary hypertension and dexfenfluramine. Lancet 339: 436, 1992.
5. Balkovetz, D. F., C. Tiruppathi, F. H. Leibach, V. B. Manesh, and V. Ganapathy. Evidence for an imipramine sensitive serotonin transporter in human placental brush-border membrane. J. Biol. Chem. 264: 2195-2198, 1989.
6. Bard, J. A., J. Zgombick, N. Adham, P. Vaysse, T. A. Branchek, and R. L. Weinshank. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 268: 23422-23426, 1993.
7. Barker, E. L., H. L. Kimmel, and R. D. Blakely. Chimeric human and rat serotonin transporters reveal domains involved in recognition of tranporter ligands. Mol. Pharmacol. 46: 799-807, 1994.
8. Becker, B. N., T. W. Gettys, J. P. Middleton, C. L. Olsen, F. J. Albers, S. L. Lee, B. L. Fanburg, and J. R. Raymond. 8-Hydroxy2-(di-n-pronylamino)tetralin-responsive 5-hydroxytryptamine 4-like receptor expressed in bovine pulmonary artery smooth muscle cells. Mol. Pharmacol. 42: 817-825, 1992.
9. Bell, L., and J. A. Madri. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 65: 1057-1065, 1989.
10. Bhargava, K. P., N. Raina, N. Misra, K. Shanker, and S. Vrat. Uptake of serotonin by human platelets and its relevance to CNS involvement in hypertension. Life Sci. 25: 195-200, 1979.
11. Bhat, G. B., and E. R. Block. Effect of hypoxia on phospholipid metabolism in porcine pulmonary artery endothelial cells. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L606-L613, 1992.
12. Blakely, R. D., H. E. Berson, R. T. Freemeau, Jr., M. G. Caron, M. M. Peck, H. K. Prince, and C. C. Bradley. Cloning and expression of a functional serotonin transporter from rat brain. Nature 354: 66-70, 1991.
13. Blauw, G. J., P. van Brummelen, C. J. Doorenbos, E.A. van der Velde, and P. A. van Zwieten. The acute and chronic antihypertensive effect of ketanserin cannot be explained by blockade of vascular serotonin type 2 receptor or α-adrenergic receptors. Clin. Pharmacol. Ther. 49: 377-384, 1991.
14. 2 exposure. J. Appl. Physiol. 42: 33-38, 1977.
15. Block, E. R., and A. B. Fisher. Effect of hyperbaric oxygen exposure on pulmonary clearance of 5-hydroxytryptamine. J. Appl. Physiol. 43: 254-257, 1977.
16. 2 tension. J. Appl. Physiol. 50: 1212-1219, 1981.
17. Bonate, P.L. Serotonin receptor subtypes: function, physiological, and clinical correlates. Clin. Neuropharmacol. 14: 1-16, 1991.
18. Bradley, B. B., G. Engel, W. Feniuk, J. R. Fozard, P. A. Humphrey, D. N. Middlemiss, J. Myelcharaneiz, B. P. Richardson, and P. R. Saxena. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563-576, 1986.
19. Brenot, F., P. Herve, P. Petitpretz, F. Parent, P. Duroux, and G. Simonneau. Primary pulmonary hypertension and fenfluramine use. Br. Heart J. 70: 537-541, 1993.
20. 1D receptors. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 291: 209-211, 1995.
21. 1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma (Abstract). Eur. J. Pharmacol. 268: 425, 1994.
22. Celada, P., F. Martin, and F. Artigas. Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. Life Sci. 55: 1237-1243, 1994.
23. Chang, A. S., S. M. Chang, D. M. Starnes, and R. D. Blakely. Cloning and expression of brain serotonin transporter. Soc. Neurosci. Abstr. 19: 495, 1993.
24. Chang, A. S. S., J. V. Franka, D. Chen, and D. M. Lam. Characterization of a genetically reconstituted high affinity system for serotonin transport. Proc. Natl. Acad. Sci. USA 86: 9611-9615, 1989.
25. 2 binding site in rat cerebral cortex but not in sub-cortical region. J. Pharmacol. Exp. Ther. 234: 195-203, 1985.
26. Conn, P. J., E. Sanders-Bush, B. J. Hoffman, and P. R. Hartig. A unique serotonin receptor in choroid plexus is linked to phosphatidyl inositol turnover. Pro. Natl. Acad. Sci. USA 83: 4086-4088, 1986.
27. Cool, D. R., F. H. Liehach, V. K. Bhallass, V. B. Mahesh, and V. Ganapathy. Expression and cyclic-AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J. Biol. Chem. 266: 15750-15757, 1991.
28. Cool, D. R., F. H. Liebach, and V. Ganapathy. Interaction of fluoxetine with the human placental serotonin transporter. Biochem. Pharmacol. 40: 2161-2167, 1990.
29. Corey, J. L., M. W. Quick, N. Davidson, H. A. Lester, and J. Guastella. A cocaine-sensitive Drosophola serotonin transporter: cloning, expression, and electrophysiological characterization. Proc. Natl. Acad. Sci. USA 91: 1188-1192, 1994.
30. Corson, M. A., R. W. Alexander, and B. C. Berk. 5-HT2 receptor mRNA is overexpressed in cultured rat aortic smooth muscle cells relative to normal aorta. Am. J. Physiol. 262 (Cell Physiol. 31): C309-C315, 1992.
31. Coughlin, S. R., M. A. Moskowitz, H. N. Antoniades, and L. Levine. Serotonin receptor-mediated stimulation of bovine smooth muscle cell prostacyclin synthesis and its modulation by platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 78: 7134-7138, 1981.
32. Crawford, N. Plasma free serotonin (5-hydroxytryptamine). Clin. Chim. Acta 8: 39-45, 1963.
33. Crowley, S. T., E. C. Dempsey, K. B. Horwitz, and L. D. Horwitz. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation 90: 1908-1918, 1994.
34. 2 receptor sites. J. Biol. Chem. 260: 7603-7608, 1985.
35. Demchyshyn, L. L., Z. B. Pristupa, K. S. Sugamori, E. L. Barker, R. D. Blakely, W. J. Wolfgang, M. A. Forte, and H. B. Niznik. Cloning expression and localization of a chloride-facilitated cocaine-sensitive serotonin transporter from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 91: 5158-5162, 1994.
36. De Vivo, M., and S. Maayami. Characterization of 5-hydroxytryptamine 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238: 248-253, 1986.
37. Douglas, J. G., J. F. Munro, A. H. Kitchen, A. L. Muin, and A. T. Proudfoot. Pulmonary hypertension and fenfluramine. Br. Med. J. 283: 881-883, 1981.
38. 5 smooth muscle cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 333: 98-103, 1986.
39. Dumuis, A., R. Bouhelal, M. Sebben, R. Cory, and J. Bockaert. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol. 34: 880-887, 1988.
40. Dumuis, A., M. Sebben, and J. Bockaert. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol. Pharmacol. 33: 178-186, 1988.
41. Enjalbert, A., S. Bourgoin, M. Hamon, J. Adrien, and J. Bockaert. Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. Mol. Pharmacol. 14: 2-10, 1978.
42. Erickson, J. D., L. E. Eiden, and B. J. Hoffman. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 89: 10993-10997, 1992.
43. Erspamer, V. Occurrence of indolealkylamines in nature. 5-Hydroxytryptamine and related alkylamines In: Handbuch der Experimentellen Pharmakologic, edited by V. Espamer. Berlin: 1996, vol. 19, p. 132-181.
44. 1a receptor. Nature 335: 358-360, 1988.
45. Franka, J. V., A. S. Chang, and D. M. Lam. Pharmacological characteristics of high-affinity serotonin uptake systems established through gene transfer. J. Pharmacol. Exp. Ther. 256: 734-740, 1991.
46. Frazer, A., S. Maayani, and B. B. Wolfe. Subtypes of receptors for serotonin. Annu. Rev. Pharmacol. 30: 307-348, 1990.
47. Gallaher, T. K., and H. H. Wang. Purification and reconstitution of serotonin receptors from bovine brain. Proc. Natl. Acad. Sci. USA 85: 2378-2382, 1988.
48. Garrison, J. C. Histamine, bradykinin, 5-hydroxytryptamine and their antogonists. In: The Pharmacological Basis of Therapeutics, edited by A. G. Gilman, T. W. Rall, A. S. Nies, and P. Taylor. New York: Pergamon, 1990, p. 592-599.
49. Geisterfer, A. A. T., and G. K. Owens. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells. Hypertension 14: 413-420, 1989.
50. Geisterfer, A. A. T., M. J. Peach, and G. K. Owens. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756, 1988.
51. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. Vascular smooth muscle cell hypertrophy vs hyperplasia. J. Clin. Invest. 90: 456-461, 1992.
52. 1 and 5-hydroxytryptamine removal in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 134: 739-744, 1986.
53. Goldman, W. F. Spatial and temporal resolution of serotonin-induced changes in intracellular calcium in a cultured arterial smooth muscle cell line. Blood Vessels 28: 252-261, 1991.
54. Golino, P., F. Piscione, C. R. Benedict, H. V. Anderson, M. Cappelli-Bigazzi, C. Indolfi, M. Condorelli, M. Chiariello, and J. T. Willerson. Local effect of serotonin released during coronary angioplasty. N. Engl. J. Med. 330: 523-528, 1994.
55. Gripenkery, J. Inhibition by reserpine, guanethidine and imipramine of the uptake of 5-hydroxytryptamine by rat peritoneal mast cells in vitro. Acta Physiol. Scand. 96: 407-416, 1976.
56. Hamanori, Y., M. Yokoyama, M. Yamada, H. Akita, K. Goshima, and H. Fukuzak. 5-Hydroxytryptamine induces phospholipase C-mediated hydrolysis of phosphoinositides through 5-hydroxytryptamine-2 receptors in cultured fetal mouse ventricular myocytes. Circ. Res. 66: 1473-1483, 1990.
57. 1D-type serotonin receptor. Mol. Pharmacol. 40: 143-148, 1991.
58. Hardisty, R. M., and R. S. Stacey. 5-Hydroxytryptamine in normal human platelets. J. Physiol. (Lond.) 130: 711-720, 1955.
59. 2 receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension. Acta Med. Scand. 222: 307-310, 1987.
60. Herve, P., L. Drouet, C. Dosquet, J. M. Launay, B. Rain, G. Simonneau, J. Caen, and P. Duroux. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am. J. Med. 89: 117-120, 1990.
61. Herve, P., J.-M. Launay, M.-L. Scrbohaci, F. Brenot, G. Simonneau, P. Petitpretz, P. Poubeau, J. Cerrina, P. Duroux, and L. Drouet. Increased plasma serotonin in primary pulmonary hypertension. Am. J. Med. 99: 249-254, 1995.
62. 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 7: 894-903, 1987.
63. 1A binding sites. Eur. J. Pharmacol. 122: 279-282, 1986.
64. Hill, N. S., S. L. Lee, P. Jederlinic, and B. L. Fanburg. Effects of chronic in vivo exposure to hypoxia on serotonin uptake by isolated rat lungs. Gen. Pharmacol. 21: 943-947, 1990.
65. Hoffman, B. J., E. Mezey, and M. J. Brownstein. Cloning of a serotonin transporter affected by anti-depressants. Science 254: 579-580, 1991.
66. Hollenberg, N. K. Segmental vascular responses to serotonin. In: Serotonin and the Cardiovascular System, edited by P. M. Vanhoutte. New York: Raven, 1985, p. 165-169.
67. Humphrey, J. H., and C. C. Toh. Absorption of serotonin (5-hydroxytryptamine) and histamine by dog platelets. J. Physiol. (Lond.) 124: 300-304, 1954.
68. Humphrey, P. P. A. Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology 23: 1503-1510, 1984.
69. Humphreys, C. J., J. Levin, and G. Rudnick. Antidepressant binding to the porcine and human platelet serotonin transporters. Mol. Pharmacol. 33: 657-663, 1988.
70. Isambert, M.-F., B. Casnier, D. Botton, and J.-P. Henry. Characterization and purification of the monoamine transporter of bovine chromaffin granules. Biochemistry 31: 1980-1986, 1992.
71. Ishizuka, J., R. D. Beauchamp, C. M. Townsend, Jr., G. H. Greeley, Jr., and J. C. Thompson. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J. Cell. Physiol. 150: 1-7, 1992.
72. Iwasawa, Y. C., C. N. Gillis, and G. Aghajanian. Hypothermic inhibition of 5-hydroxytryptamine and norepinephrine uptake by lung: cellular location of amines after uptake. J. Pharmacol. Exp. Ther. 186: 498-507, 1973.
73. Jacobs, B. L., and E. C. Azmitia. Review of the anatomy and physiology of the central nervous system (CNS) serotonin in vertebrates. Physiol. Rev. 72: 165-215, 1992.
74. Jin, H., D. Oksenberg, A. Ashkenazi, S. J. Peroutka, A. M. Duncan, R. Rozmahel, Y. Yang, G. Mengod, J. M. Palacios, and B. F. O'Dowd. Characterization of the human 5-hydroxytryptamine 1B receptor. J. Biol. Chem. 267: 5735-5738, 1992.
75. 2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc. Natl. Acad. Sci. USA 87: 928-932, 1990.
76. Julius, D., A. B. MacDermott, R. Axel, and T. M. Jessell. Molecular characterization of a functional cDNA encoding the serotonin 1C receptor. Science 241: 558-564, 1988.
77. 14C-5-hydroxytryptamine in isolated perfused rat lungs. J. Pharmacol. Exp. Ther. 183: 341-355, 1972.
78. 3H-serotonin and endogenous content of serotonin in blood platelet in hypertension patients. Hypertension 6: 568-573, 1984.
79. Kavanaugh, W. M., L. T. Williams, H. E. Ives, and S. R. Coughlin. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol. Endocrinol. 2: 599-605, 1988.
80. Kendall, D. A., and S. R. Nahorski. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J. Pharmacol. Exp. Ther. 233: 473-479, 1985.
81. Kent, T. A., A. Jazayeri, and J. M. Simard. Serotonin as a vascular smooth muscle cell mitogen. In: Serotonin, Molecular Biology, Receptors and Functional Effects, edited by J. R. Fozard and P. R. Saxena. Basel: Birkhauser Verleg, 1991, p. 398-405.
82. 3H]thymidine incorporation in cultured cerebral smooth muscle cells. J. Cereb. Blood Flow Metab. 12: 139-146, 1992.
83. Laplanche, J. L., P. Beaudry, J. M. Launay, C. Dreux, and Y. Goussault. Initial evidence for serotonin uptake by human peripheral blood lymphocytes. Biog. Amines 3: 193-200, 1985.
84. Lauder, J. M. Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Neuropharmacology of serotonin. Ann. NY. Acad. Sci. 600: 297-314, 1990.
85. Launay, J. M., C. Geoffroy, V. Mutel, M. Buckle, A. Cesura, J. E. Alouf, and M. D. Prada. One step purification of the serotonin transporter located at the human platelet plasma membrane. J. Biol. Chem. 267: 11344-11351, 1992.
86. Lee, S. L., J. Dunn, F. S. Yu, and B. L. Fanburg. Serotonin uptake and configurational change of bovine pulmonary artery smooth muscle cells in culture. J. Cell. Physiol. 138: 145-153, 1989.
87. Lee, S. L., and B. L. Fanburg. Serotonin uptake by bovine pulmonary artery endothelial cells in culture. I. Characterization. Am. J. Physiol. 250 (Cell Physiol. 19): C761-C765, 1986.
88. Lee, S. L., and B. L. Fanburg. Serotonin uptake by pulmonary artery endothelial cells in culture. II. Stimulation by hypoxia. Am. J. Physiol. 250 (Cell Physiol. 19): C766-C770, 1986.
89. Lee, S. L., and B. L. Fanburg. Glycolytic activity and enhancement of serotonin uptake by endothelial cells exposed to hypoxia/anoxia. Circ. Res. 60: 653-658, 1987.
90. Lee, S. L., and B. L. Fanburg. Beta adrenergic antagonists inhibit serotonin uptake by pulmonary vascular cells in culture. J. Pharmacol. Exp. Ther. 257: 895-900, 1991.
91. Lee, S. L., and B. L. Fanburg. Serotonin produces a configurational change of cultured smooth muscle cells that is associated with elevation of intracellular cAMP. J. Cell. Physiol. 150: 396-405, 1992.
92. 2+ channel blockade. J. Cell. Physiol. 132: 178-182, 1987.
93. Lee, S. L., W. W. Wang, and B. L. Fanburg. Nitroprusside inhibits serotonin-induced mitogenesis and tyrosine phosphorylation of smooth muscle cells. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14): L362-L367, 1996.
94. Lee, S. L., W. W. Wang, and B. L. Fanburg. Association of tyrosine phosphorylation of GTPase activating protein with mitogenic action of serotonin. Am. J. Physiol. 272 (Cell Physiol. 41): C223-C230, 1997.
95. Lee, S. L., W. W. Wang, P. M. Joseph, C. Hales, and B. L. Fanburg. Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells. Am. J. Respir. Cell Mol. Biol. In press.
96. Lee, S. L., W. W. Wang, J. J. Lanzillo, and B. L. Fanburg. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L46-L52, 1994.
97. Lee, S. L., W. W. Wang, J. J. Lanzillo, and B. L. Fanburg. Regulation of serotonin-induced DNA synthesis of bovine pulmonary artery smooth muscle cells. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L53-L60, 1994.
98. Lee, S. L., W. W. Wang, B. J. Moore, and B. L. Fanburg. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cell in culture. Circ. Res. 68: 1362-1368, 1991.
99. Liu, Y. F., and P. R. Albert. Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinase C and A. J. Biol. Chem. 266: 23689-23697, 1991.
100. 1c receptor by electrophysiological assays of mRNA-injected Xenopius oocytes. Proc. Natl. Acad. Sci. USA 84: 4332-4336, 1987.
101. Macusson, J. O., and S. B. Ross. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology 102: 145-155, 1990.
102. 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol. Pharmacol. 43: 313-319, 1993.
103. McMurray, J., P. Bloomfield, and H. C. Miller. Irreversible pulmonary hypertension after treatment with fenfluramine. Br. Med. J. 292: 239-240, 1986.
104. Melmon, K. L. The endocrinologie manifestations of the carcinoid tumor. In: Textbook of Endocrinology, edited by R. H. Williams. Philadelphia, PA: Saunders, 1968, p. 166.
105. Mene, P., F. Pugliese, and G. A. Cinotti. Serotonin and the glomerular mesangium. Mechanisms of intracellular signaling. Hypertension 17: 151-160, 1991.
106. Merker, M. P., and C. N. Gillis. Propanolol and serotonin removal in lung injury. J. Appl. Physiol. 65: 2579-2584, 1988.
107. Mitsuhashi, M., and D. G. Payan. The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines. Life Sci. 40: 853-961, 1987.
108. Murphy, T. J., and D. B. Bylund. Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from opossum. J. Pharmacol. Exp. Ther. 249: 535-543, 1989.
109. Nakaki, T., B. C. Wise, D. M. Chuang, and R. Kato. Serotonin-stimulated protein phosphorylation in aortic smooth muscle cells. Experientia 45: 879-881, 1989.
110. Nemecek, G. M., S. R. Coughlin, D. A. Handley, and M. A. Moskowitz. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. USA 83: 674-678, 1986.
111. Nicoll, R. A. The cloning of neurotransmitter receptors to ion channels in the brain. Science 241: 545-550, 1988.
112. 3H]serotonin into plasma membrane vesicles from mouse cerebral cortex. J. Biol. Chem. 263: 6115-6121, 1988.
113. Ozaki, M., A. Himeno, S. Uchida, H. Ohta, and M. Niwa. Accelerated uptake of serotonin in mesenteric arteries of young spontaneously hypertensive rats. J. Hypertens. 4, Suppl. 3: S227-S228, 1986.
114. Pakala, R., J. T. Willerson, and C. R. Benedict. Mitogenic effect of serotonin on vascular endothelial cells. Circulation 90: 1919-1926, 1994.
115. Parrott, D. P., P. M. Lockey, and C. P. Bright. Comparison of the mitogenic activity of angiotensin II and serotonin on porcine arterial smooth muscle cells. Atherosclerosis 88: 213-218, 1991.
116. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem. Pharmacol. 45: 375-383, 1993.
117. Pazos, A., D. Hoyer, and J. M. Palacios. The binding of serotonergic ligands to the porcine choroid plexus. Characterization of a new type of serotonergic recognition site. Eur. J. Pharmacol. 106: 539-546, 1984.
118. Pearson, J. D., H. J. Olverman, and J. L. Gordon. Transport of 5-hydroxytryptamine by endothelial cells. Biochem. Soc. Trans. 5: 1181-1183, 1977.
119. 3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36: 220-226, 1981.
120. Pitt, B. R., W. Weng, A. R. Steve, R. D. Blakely, I. Reynolds, and P. Davies. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L178-L186, 1994.
121. Pouwels, H. M. M., J. L. R. M. Smeets, D. C. Cheriex, and E. F. M. Wouters. Pulmonary hypertension and fenfluramine. Eur. Respir. J. 3: 606-607, 1990.
122. Pritchett, D. B., A. W. J. Bach, M. Wozny, O. Taleb, R. Dal Toso, J. C. Shih, and P. H. Seeburg. Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J. 7: 4135-4140, 1988.
123. Ramamoorthy, S., A. L. Bauman, K. R. Moore, H. Han, T. Yang-Feng, A. S. Chang, V. Ganapathy, and R. D. Blakely. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc. Natl. Acad. Sci. USA 90: 2542-2546, 1993.
124. Rapport, M. M., A. A. Green, and I. H. Page. Serum vasoconstrictor (serotonin) IV. Isolation and characterization. J. Biol. Chem. 176: 1243-1251, 1948.
125. 1 receptors in HeLa cells stimulate phosphoinositide hydrolysis and phosphate uptake via distinct G protein pools. J. Biol. Chem. 266: 372-379, 1991.
126. Robinson-White, A., S. Peterson, H. B. Hechtman, and D. Shepro. Serotonin uptake by isolated adipose capillary endothelium. J. Pharmacol. Exp. Ther. 216: 125-128, 1981.
127. Roche, N., S. Labrume, J. M. Braun, and G. J. Huchon. Pulmonary hypertension and dexfenfluramine. Lancet 339: 436-437, 1992.
128. Rosoff, C. B., E. W. Salzman, and V. Gurewich. Reduction of platelet serotonin and the response to pulmonary emboli. Surgery 70: 12-19, 1971.
129. 2 receptors coupled to phospholipase C in rat aorta: modulation of phosphonositide turnover by phorbol ester. J. Pharmacol. Exp. Ther. 238: 480-485, 1986.
130. 7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90: 8547-8551, 1993.
131. Rudnick, G. Active transport of a hydroxytryptamine by plasma membrane vesicles isolated from human isolated platelets. J. Biol. Chem. 252: 2170-2174, 1977.
132. Rudnick, G., R. Benwya, P. J. Nelson, and R. A. Zito, Jr. Inhibition of platelet serotonin transport by propranolol. Mol. Pharmacol. 20: 118-123, 1981.
133. Sato, K., S. Webb, A. Tucker, M. Rabinovitch, R. F. O'Brian, I. F. McMurtry, and T. J. Stelzner. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rats. Am. Rev. Respir. Dis. 145: 793-797, 1992.
134. Schmidt, A. W., and S. J. Peroutka. 5-Hydroxytryptamine receptor "families." FASEB J. 3: 2242-2249, 1989.
135. 3H]-5-hydroxytryptamine binding sites, species and tissue variation. J. Neurochem. 42: 65-70, 1984.
136. Scott, A. K., P. R. Chaudhury, J. Webster, and J. C. Petrie. Selective 5-HT antagonist (ICI 169, 369): lack of effect on blood pressure in hypertension patients (Abstract). Br. J. Clin. Pharmacol. 25: 651p, 1988.
137. i-protein. Nature 335: 254-256, 1988.
138. Seuwen, K., and J. Pouyssegur. Serotonin as a growth factor. Biochem. Pharmacol. 39: 985-990, 1990.
139. Shepro, D., J. C. Batbouta, L. S. Robolee, M. P. Carson, and T. A. Delamarich. Serotonin transport by cultured bovine aortic endothelium. Circ. Res. 36: 799-806, 1975.
140. Shuttleworth, R. D., and J. R. O'Brien. Intraplatelet serotonin and plasma hydroxyindoles in health and disease. Blood 57: 505-509, 1981.
141. Stein, M., and D. P. Thomas. Role of platelet in the acute pulmonary response to endotoxin. J. Appl. Physiol. 23: 47-52, 1967.
142. Stern-Bach, Y., N. Greenbug-Ofrath, I. Flechner, and S. Schuldiner. Identification and purification of a functional amine transporter from bovine chromaffin granules. J. Biol. Chem. 265: 3961-3966, 1990.
143. Stouffer, G. A., and G. K. Owens. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ. Res. 70: 820-828, 1992.
144. Stroebel, M., and M. Groppelt-Struebe. Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J. Biol. Chem. 269: 22952-22957, 1994.
145. Synder, S. H. Overview of neurotransmitter receptor binding. In: Neurotransmitter Receptor Binding, edited by H. I. Yamamura, S. J. Enna, and M. J. Kuhar. New York: Raven, 1978, p. 1-12.
146. Takuwa, N., M. Ganz, Y. Takuwa, R. B. Sterzel, and H. Rasmussen. Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol. 26): F431-F439, 1989.
147. Tranzer, J. P., M. Da Prada, and A. Pletcher. Ultrastructural localization of 5-hydroxytryptamine in blood platelet. Nature 212: 1574-1575, 1966.
148. Tschopp, T. B., and M. B. Zucker. Hereditary defect in platelet function in rats. Blood 40: 217-226, 1972.
149. Udenfriend, S., and H. Weissbach. Turnover of 5-hydroxytryptamine (serotonin) in tissue. Proc. Soc. Exp. Biol. Med. 97: 748-751, 1958.
150. Vanhoutte, P. M. 5-HT and vascular disease. Federation Proc. 42: 233-237, 1983.
151. Vankova, M., and J. Grunwald. Effect of serotonin and 5-hydroxyindole-3-acetic acid on smooth muscle proliferation. Med. Sci. Res. 15: 1261-1262, 1987.
152. 1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 120: 227-230, 1986.
153. Williams, D. C., and O. M. Phillips. Probing the platelet membrane 5-hydroxytryptamine transporter. Biochem. Soc. Trans. 19: 112-114, 1991.
154. Yu, F. S., S. L. Lee, J. J. Lanzillo, and B. L. Fanburg. Endothelial cell inhibition of hypoxia-induced stimulation of serotonin uptake by vascular smooth muscle cells. Am. Rev. Respir. Dis. 139: 1144-1148, 1989.
155. Zachary, I., J. W. Penella, and E. Rozengurt. A role for neuropeptides in the control of cell proliferation. Dev. Biol. 124: 295-308, 1987.
156. Zifa, E., and G. Fillion. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44: 401-458, 1992.